세계의 무균 바이알 시장 조사 보고서 : 산업 분석, 규모, 점유율, 성장, 동향, 예측(2024-2032년)

The global demand for Sterile Vials Market is presumed to reach the market size of nearly USD 13.42 Billion by 2032 from USD 6.4 Billion in 2023 with a CAGR of 8.57% under the study period 2024-2032.

A sterile vial is a container utilized for sample collection where aseptic procedures are obligatory. These vials are manufactured using sterile equipment and techniques and sealed to prevent contamination. A sterile vial is generally used for plasma samples or collecting blood in a research facility or hospital setting where sterilization is a priority. Sterile vials and bottles are available in various sizes and colors to accommodate a wide range of needs in the industry. But the most typical are small glass containers sealed with an aluminum lid and rubber stopper. Empty vials are usually used to mix ingredients, solutions, medications, and other liquids. During sterile sample collection and processing, the user or handler should wear appropriate gloves.

MARKET DYNAMICS

Sterility plays a vital role in hospitals, clinical labs, compounding labs, biopharmaceutical companies, and CMOs. Any carelessness can lead to detrimental effects on human life. Rising demand from end-users is steering the global sterile vials market. Rising governmental investments in the biopharmaceutical sector and expanding research to bring new treatment further stimulated market growth. COVID-19 pandemic impacted positively on the global sterile vials market due to exponential demand for drugs. The market is predicted to remain exciting owing to the vaccination practices on-going worldwide. Key companies are investing in bringing in a more advanced range of products. The covid-19 pandemic has caused advancements in manufacturing sterile vials.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Sterile Vials. The growth and trends of Sterile Vials industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Sterile Vials market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

• Sterile Empty Vial (Sterile Evacuated Vial, Sterile Nitrogen Filled Vial, Sterile Air Filled Vial)
• Sterile Liquid Filled Vial (Sterile Saline Filled Vial, Sterile Media Filled Vial, Sterile Water Filled Vial)
• Individual Sterilized Components (ISCs)

By Volume

• <2 ml
• 2 ml to 5 ml
• 5 ml to 10 ml
• 10 ml to 20 ml
• >20 ml

By Material

• Glass
• Plastic

By End User

• Clinical Labs
• Compounding Labs
• Biopharmaceutical Companies
• CMOs
• Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Sterile Vials market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Sterile Vials market include Adelphi Healthcare Packaging, APG Europe, Bormioli Pharma S.P.A., Corning Incorporated, Dalton Pharma Services, DWK Life Sciences GmbH, Gerresheimer AG, NiprCorporation, OBerk Company, Pacific Vial, Piramal Glass (Piramal Enterprises Ltd), Schott AG, SDG Pharma, Shandong Pharmaceutical Glass Co. Ltd., Si02 Materials Science, StevanatGroup, ThermFisher Scientific Inc., West Pharmaceutical Services Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

• 1.1. Report Description
  • 1.1.1 Objective
  • 1.1.2 Target Audience
  • 1.1.3 Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1 Market Research Process
  • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3. STERILE VIALS - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Product
  • 3.7.2 Market Attractiveness Analysis By Volume
  • 3.7.3 Market Attractiveness Analysis By Material
  • 3.7.4 Market Attractiveness Analysis By End User
  • 3.7.5 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1 List of Raw Materials
  • 4.2.2 Raw Material Manufactures List
  • 4.2.3 Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1 Direct Marketing
  • 4.4.2 Indirect Marketing
  • 4.4.3 Marketing Channel Development Trend

5. GLOBAL STERILE VIALS MARKET ANALYSIS BY PRODUCT

• 5.1. Overview By Product
• 5.2. Historical and Forecast Data Analysis By Product
• 5.3. Sterile Empty Vial (Sterile Evacuated Vial, Sterile Nitrogen Filled Vial, Sterile Air Filled Vial) Historic and Forecast Sales By Regions
• 5.4. Sterile Liquid Filled Vial (Sterile Saline Filled Vial, Sterile Media Filled Vial, Sterile Water Filled Vial) Historic and Forecast Sales By Regions
• 5.5. Individual Sterilized Components (ISCs) Historic and Forecast Sales By Regions

6. GLOBAL STERILE VIALS MARKET ANALYSIS BY VOLUME

• 6.1. Overview By Volume
• 6.2. Historical and Forecast Data Analysis By Volume
• 6.3. <2 ml Historic and Forecast Sales By Regions
• 6.4. 2 ml to 5 ml Historic and Forecast Sales By Regions
• 6.5. 5 ml to 10 ml Historic and Forecast Sales By Regions
• 6.6. 10 ml to 20 ml Historic and Forecast Sales By Regions
• 6.7. >20 ml Historic and Forecast Sales By Regions

7. GLOBAL STERILE VIALS MARKET ANALYSIS BY MATERIAL

• 7.1. Overview By Material
• 7.2. Historical and Forecast Data Analysis By Material
• 7.3. Glass Historic and Forecast Sales By Regions
• 7.4. Plastic Historic and Forecast Sales By Regions

8. GLOBAL STERILE VIALS MARKET ANALYSIS BY END USER

• 8.1. Overview By End User
• 8.2. Historical and Forecast Data Analysis By End User
• 8.3. Clinical Labs Historic and Forecast Sales By Regions
• 8.4. Compounding Labs Historic and Forecast Sales By Regions
• 8.5. Biopharmaceutical Companies Historic and Forecast Sales By Regions
• 8.6. CMOs Historic and Forecast Sales By Regions
• 8.7. Others Historic and Forecast Sales By Regions

9. GLOBAL STERILE VIALS MARKET ANALYSIS BY GEOGRAPHY

• 9.1. Regional Outlook
• 9.2. Introduction
• 9.3. North America Sales Analysis
  • 9.3.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.3.2 North America By Segment Sales Analysis
  • 9.3.3 North America By Country Sales Analysis
  • 9.3.4 United States Sales Analysis
  • 9.3.5 Canada Sales Analysis
  • 9.3.6 Mexico Sales Analysis
• 9.4. Europe Sales Analysis
  • 9.4.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.4.2 Europe By Segment Sales Analysis
  • 9.4.3 Europe By Country Sales Analysis
  • 9.4.4 United Kingdom Sales Analysis
  • 9.4.5 France Sales Analysis
  • 9.4.6 Germany Sales Analysis
  • 9.4.7 Italy Sales Analysis
  • 9.4.8 Russia Sales Analysis
  • 9.4.9 Rest Of Europe Sales Analysis
• 9.5. Asia Pacific Sales Analysis
  • 9.5.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.5.2 Asia Pacific By Segment Sales Analysis
  • 9.5.3 Asia Pacific By Country Sales Analysis
  • 9.5.4 China Sales Analysis
  • 9.5.5 India Sales Analysis
  • 9.5.6 Japan Sales Analysis
  • 9.5.7 South Korea Sales Analysis
  • 9.5.8 Australia Sales Analysis
  • 9.5.9 South East Asia Sales Analysis
  • 9.5.10 Rest Of Asia Pacific Sales Analysis
• 9.6. Latin America Sales Analysis
  • 9.6.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.6.2 Latin America By Segment Sales Analysis
  • 9.6.3 Latin America By Country Sales Analysis
  • 9.6.4 Brazil Sales Analysis
  • 9.6.5 Argentina Sales Analysis
  • 9.6.6 Peru Sales Analysis
  • 9.6.7 Chile Sales Analysis
  • 9.6.8 Rest of Latin America Sales Analysis
• 9.7. Middle East & Africa Sales Analysis
  • 9.7.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.7.2 Middle East & Africa By Segment Sales Analysis
  • 9.7.3 Middle East & Africa By Country Sales Analysis
  • 9.7.4 Saudi Arabia Sales Analysis
  • 9.7.5 UAE Sales Analysis
  • 9.7.6 Israel Sales Analysis
  • 9.7.7 South Africa Sales Analysis
  • 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE STERILE VIALS COMPANIES

• 10.1. Sterile Vials Market Competition
• 10.2. Partnership/Collaboration/Agreement
• 10.3. Merger And Acquisitions
• 10.4. New Product Launch
• 10.5. Other Developments

11. COMPANY PROFILES OF STERILE VIALS INDUSTRY

• 11.1. Top Companies Market Share Analysis
• 11.2. Market Concentration Rate
• 11.3. Adelphi Healthcare Packaging
  • 11.3.1 Company Overview
  • 11.3.2 Company Revenue
  • 11.3.3 Products
  • 11.3.4 Recent Developments
• 11.4. APG Europe
  • 11.4.1 Company Overview
  • 11.4.2 Company Revenue
  • 11.4.3 Products
  • 11.4.4 Recent Developments
• 11.5. Bormioli Pharma S.P.A.
  • 11.5.1 Company Overview
  • 11.5.2 Company Revenue
  • 11.5.3 Products
  • 11.5.4 Recent Developments
• 11.6. Corning Incorporated
  • 11.6.1 Company Overview
  • 11.6.2 Company Revenue
  • 11.6.3 Products
  • 11.6.4 Recent Developments
• 11.7. Dalton Pharma Services
  • 11.7.1 Company Overview
  • 11.7.2 Company Revenue
  • 11.7.3 Products
  • 11.7.4 Recent Developments
• 11.8. DWK Life Sciences GmbH
  • 11.8.1 Company Overview
  • 11.8.2 Company Revenue
  • 11.8.3 Products
  • 11.8.4 Recent Developments
• 11.9. Gerresheimer AG
  • 11.9.1 Company Overview
  • 11.9.2 Company Revenue
  • 11.9.3 Products
  • 11.9.4 Recent Developments
• 11.10. NiprCorporation
  • 11.10.1 Company Overview
  • 11.10.2 Company Revenue
  • 11.10.3 Products
  • 11.10.4 Recent Developments
• 11.11. OBerk Company
  • 11.11.1 Company Overview
  • 11.11.2 Company Revenue
  • 11.11.3 Products
  • 11.11.4 Recent Developments
• 11.12. Pacific Vial
  • 11.12.1 Company Overview
  • 11.12.2 Company Revenue
  • 11.12.3 Products
  • 11.12.4 Recent Developments
• 11.13. Piramal Glass (Piramal Enterprises Ltd)
  • 11.13.1 Company Overview
  • 11.13.2 Company Revenue
  • 11.13.3 Products
  • 11.13.4 Recent Developments
• 11.14. Schott AG
  • 11.14.1 Company Overview
  • 11.14.2 Company Revenue
  • 11.14.3 Products
  • 11.14.4 Recent Developments
• 11.15. SDG Pharma
  • 11.15.1 Company Overview
  • 11.15.2 Company Revenue
  • 11.15.3 Products
  • 11.15.4 Recent Developments
• 11.16. Shandong Pharmaceutical Glass Co. Ltd.
  • 11.16.1 Company Overview
  • 11.16.2 Company Revenue
  • 11.16.3 Products
  • 11.16.4 Recent Developments
• 11.17. Si02 Materials Science
  • 11.17.1 Company Overview
  • 11.17.2 Company Revenue
  • 11.17.3 Products
  • 11.17.4 Recent Developments
• 11.18. StevanatGroup
  • 11.18.1 Company Overview
  • 11.18.2 Company Revenue
  • 11.18.3 Products
  • 11.18.4 Recent Developments
• 11.19. ThermFisher Scientific Inc.
  • 11.19.1 Company Overview
  • 11.19.2 Company Revenue
  • 11.19.3 Products
  • 11.19.4 Recent Developments
• 11.20. West Pharmaceutical Services Inc
  • 11.20.1 Company Overview
  • 11.20.2 Company Revenue
  • 11.20.3 Products
  • 11.20.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies